MErCuRIC study launched

Professor Tim Maughan from the Gray Institute for Radiation Oncology and Biology, University of Oxford is working on a new collaboration with the Queen’s University in Belfast who are leading a euro-wide research programme to find a new treatment for bowel cancer. This new research is being funded by the European Commission.

The MErCuRIC study, which was launched yesterday in Belfast, involves eight different countries and will look at two major genetic factors which make bowel cancer difficult to treat.

For further information please follow this link.

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.